A total of 126 patients completed the 16-week treatment period, and 124 chose to enter the open-label extended period, in which they will receive the therapy until March 2024
Yes, but it must be given in the correct dosage
The number of doses depends on the vial strength, dilution, and your chosen dose
Neither approach has proven superior
Research-Use Labelling Standards Packaging follows research-use-only conventions: for laboratory research use only, not for human or veterinary consumption, lot number, and storage instructions
Compounded methylcobalamin injections may be prescribed by a licensed healthcare provider for patients with clinically appropriate vitamin B12 deficiency or when injectable vitamin B12 supplementation is considered medically appropriate